News room
Technophage has been granted with the ‘COTEC Innovative Status 2026’
Technophage is proud to announce that it has recently been granted with the ‘COTEC Innovative Status 2026’. COTEC Portugal is the main Portuguese…
Technophage Receives Regulatory Approval to Initiate Phase 1/2a TP-122 Clinical Study in Europe
We are pleased to share an important milestone for Technophage: the Phase 1/2a clinical study TP-122_101A has recently received the necessary…
Technophage Recognized as PME Líder 2025
Once more we are thrilled to announce that Technophage has been recognized by IAPMEI, I.P. – Agência para a Competitividade e Inovação with the PME…
TP-102 Phase 2b End of Study Marks Key Step Toward Phase 3 Development
We are pleased to share that last Friday marked an important milestone for Technophage with the End of Study of the TP-102 Phase 2b clinical trial….
Technophage Awarded PME Excelência 2024 Status
We are proud to share that Technophage has been awarded the ‘PME Excelência 2024’ status. This recognition highlights companies with…